Why the study?
Does thioridazine increase the QTc interval in hospitalised subjects requiring a low-potency antipsychotic?
Population
30 hospitalised subjects in South Africa who required switching from a high-potency to a low-potency…
Comparison
Thioridazine initiated at 300 mg per day vs Baseline (pre-treatment)
Design
Cohort
Follow-up
1 week after initiation and 48 hours after each dose…
Authors
Loading...
Thioridazine was associated with QTc prolongation in this cohort; supports ECG monitoring but leaves open randomized confirmation of arrhythmic risk.
Does thioridazine increase the QTc interval in hospitalised subjects requiring a low-potency antipsychotic?
Thioridazine causes significant QTc prolongation, supporting recommendations against its use as a first-line antipsychotic and highlighting the need for regular ECG monitoring.
Seller et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: